Anthrax Vaccines
Pre- and post-exposure vaccines
This page catalogs 2 anthrax vaccine products. Anthrax vaccines have historically been used primarily for military and occupational populations at risk of exposure to Bacillus anthracis.
Last updated: April 2026.
Anthrax Vaccine Catalog
| Trade Name | Generic Designation | Manufacturer | Vaccine Type | Regulatory Status & Year | Key Notes |
|---|---|---|---|---|---|
| BioThrax | Anthrax vaccine adsorbed (AVA) | Emergent BioSolutions | Adsorbed subunit | FDA Licensed, 1970 | Only US-licensed anthrax vaccine for pre-exposure |
| Cyfendus | Anthrax vaccine adsorbed, adjuvanted (AV7909) | Emergent BioSolutions | Subunit + CpG adjuvant | FDA Licensed, 2023 | Post-exposure prophylaxis with antibiotics |
Sources
Regulatory data sourced from FDA CBER Vaccines Licensed for Use in the United States (March 2026). Catalog scope informed by Khan, Shaz, The Ultimate Vaccine Timeline.